Mitochondrial Protection
Mitochondrial Protection - Related Videos
02:59
Animal Mitochondrial Genetics
0 Views •
2020
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
05:53
Mitochondrial Ca2+ Retention Capacity Assay and Ca2+-triggered Mitochondrial Swelling Assay
0 Views •
Cited by 11 •
2018
This protocol aims to describe a method to examine the Ca2+ retention capacity and Ca2+- triggered mitochondrial swelling of isolated mitochondria of SH-SY5Y cells step-by-step.
08:40
An Optimized Protocol to Analyze Glycolysis and Mitochondrial Respiration in Lymphocytes
0 Views •
Cited by 38 •
2016
The study of metabolism is becoming increasingly relevant to immunological research. Here, we present an optimized method for measuring glycolysis and mitochondrial respiration in mouse splenocytes, and T and B lymphocytes.
09:45
Mitochondrial Isolation from Skeletal Muscle
0 Views •
Cited by 48 •
2011
This protocol describes a procedure to study the respiration of mitochondria isolated from skeletal muscles. This method was adapted from Scorrano et al. (2007). The mitochondrial isolation procedure requires about 2 hours. The mitochondrial respiration can be completed in about 1 hour.
02:16
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes
0 Views •
2020
The present-day mitochondrial and chloroplast genomes have retained some of the characteristics of their ancestral prokaryotes and also have acquired new attributes during their evolution within eukaryotic cells. Like prokaryotic genomes, mitochondrial and chloroplast genomes neither bind with histone-like proteins nor show complex packaging into chromosome-like structures, as observed in eukaryotes. Unlike mitotic cell divisions observed in eukaryotic cells, mitochondria and chloroplasts...
FAQs
Reducing oxidative stress helps protect mitochondrial structure and supports continued energy production. Excess oxidative stress can impair mitochondrial performance and contribute to loss of cellular resilience, so antioxidant strategies aim to reduce this damaging pressure. In medicine, this mechanism is especially relevant when developing interventions for tissue injury, neurodegeneration, metabolic disease, or drug-induced toxicity.
Mitochondrial membrane potential is a central indicator of mitochondrial functional stability. Protection strategies aim to maintain it because disruption can accompany impaired energy production and progression toward cell injury. Assessing whether an intervention preserves membrane potential therefore helps determine whether mitochondria remain functional under conditions associated with ischemia-reperfusion injury, disease-related stress, or toxic exposure.
Mitophagy provides a quality-control pathway that helps manage damaged mitochondria, whereas inappropriate opening of the mitochondrial permeability transition pore can trigger cell injury. Protective approaches may therefore support appropriate mitophagy while limiting harmful pore opening. Considering both processes is important because mitochondrial quality control and membrane stability address different mechanisms contributing to cellular damage.
Targeted therapeutics and metabolic interventions are designed to act on mechanisms that preserve mitochondrial performance rather than addressing cellular injury only after it occurs. Depending on the strategy, the intended effects may include limiting oxidative stress, maintaining membrane potential, supporting mitophagy, or reducing harmful pore opening. These approaches support the broader goal of improving cellular energy production and tissue resilience.
Ischemia-reperfusion injury is a major medical context for mitochondrial protection because restoring blood flow can be associated with cellular stress and mitochondrial dysfunction. Strategies that preserve membrane potential, limit oxidative stress, and reduce inappropriate permeability transition pore opening are relevant to limiting mitochondrial contributions to injury. The desired outcome is greater tissue resilience during this damaging clinical process.
These conditions differ clinically, but each provides a setting in which preserving mitochondrial structure and function may be important. Protective research examines whether antioxidant, targeted, or metabolic strategies can maintain energy production and reduce cellular injury across these contexts. The approach is therefore not limited to one disease, while the relevant mitochondrial stress mechanisms may vary among applications.